Our guest in this new episode is an academic super star: Prof. Carmit Levy who is the Chair of the Department of Human Molecular Genetics & Biochemistry at the Gray Faculty of Medicine. Levy is a renowned researcher in the area of skin cancer.

Prof. Levy and her team recently made a groundbreaking discovery involving a protein called Ly6a, which acts as a “brake” on the immune system. This protein, expressed both after UV exposure and in tumors, prevents immune cells from attacking cancer effectively. In experimental studies, the team showed that blocking Ly6a with a specific antibody reactivated the immune response, causing tumors to shrink—even in cases resistant to existing immunotherapies.This research, published in Nature Communications, not only advances our understanding of the immune system but also points toward entirely new treatment possibilities. Join us as we explore with Prof. Levy how this discovery was made, its future potential, and what it means for the fight against cancer.

__________________

Tel Aviv 360, Israel's largest and most diverse podcast about research and innovation

• Tel Aviv 360 in Facebook ◄ ⁠⁠⁠⁠⁠⁠⁠⁠https://360tau.com/Facebook⁠⁠⁠⁠⁠⁠⁠⁠

• Tel Aviv 360 in WhatsApp (Silent group) ◄ ⁠⁠⁠⁠⁠⁠⁠⁠https://360tau.com/WhatsApp⁠⁠⁠⁠⁠⁠⁠⁠

• Tel Aviv 360 in Spotify ◄⁠⁠⁠⁠⁠⁠⁠⁠ https://360tau.com/Spotify⁠⁠⁠⁠⁠⁠⁠⁠

• Tel Aviv 360 official website ◄ ⁠⁠⁠⁠⁠⁠⁠⁠https://360tau.com⁠⁠⁠⁠